UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 10-Q
(Mark One)
|
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
For the quarterly period ended June 30, 2020 |
|
|
|
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
For the transition period _______ to _______ |
Commission file number:001-33660
CLEARONE, INC.
(Exact name of registrant as specified in its charter)
|
Delaware |
|
87-0398877 |
|
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. employer identification number) |
|
|
|
|
|
5225 Wiley Post Way, Suite 500, Salt Lake City, Utah |
|
84116 |
|
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (801) 975-7200
Indicate by check whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
|
Larger Accelerated Filer ☐ |
Accelerated Filer ☐ |
|
Non-Accelerated Filer ☒ |
Smaller Reporting Company ☒ |
|
|
Emerging Growth Company ☐ |
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
Common Stock, $0.001 |
|
CLRO |
|
The NASDAQ Capital Market |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No
The number of shares of ClearOne common stock outstanding as of August 13, 2020 was 16,655,207.
CLEARONE, INC.
QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2020
INDEX
CLEARONE, INC
(Dollars in thousands, except par value)
|
|
|
June 30, 2020 |
|
|
December 31, 2019 |
|
||
|
ASSETS |
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
2,106 |
|
|
$ |
4,064 |
|
|
Marketable securities |
|
|
2,841 |
|
|
|
3,026 |
|
|
Receivables, net of allowance for doubtful accounts of $455 and $424, respectively |
|
|
5,792 |
|
|
|
5,468 |
|
|
Inventories, net |
|
|
8,224 |
|
|
|
11,441 |
|
|
Prepaid expenses and other assets |
|
|
957 |
|
|
|
1,184 |
|
|
Total current assets |
|
|
19,920 |
|
|
|
25,183 |
|
|
Long-term marketable securities |
|
|
1,130 |
|
|
|
1,517 |
|
|
Long-term inventories, net |
|
|
6,510 |
|
|
|
6,284 |
|
|
Property and equipment, net |
|
|
1,050 |
|
|
|
1,044 |
|
|
Operating lease - right of use assets, net |
|
|
2,227 |
|
|
|
2,459 |
|
|
Intangibles, net |
|
|
17,141 |
|
|
|
14,009 |
|
|
Other assets |
|
|
4,593 |
|
|
|
4,614 |
|
|
Total assets |
|
$ |
52,571 |
|
|
$ |
55,110 |
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
3,172 |
|
|
$ |
2,871 |
|
|
Accrued liabilities |
|
|
2,782 |
|
|
|
3,205 |
|
|
Deferred product revenue |
|
|
201 |
|
|
|
173 |
|
|
Total current liabilities |
|
|
6,155 |
|
|
|
6,249 |
|
|
Long-term debt |
|
|
3,819 |
|
|
|
2,222 |
|
|
Operating lease liability, net of current |
|
|
1,767 |
|
|
|
2,021 |
|
|
Other long-term liabilities |
|
|
111 |
|
|
|
140 |
|
|
Total liabilities |
|
|
11,852 |
|
|
|
10,632 |
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' equity: |
|
|
|
|
|
|
|
|
|
Common stock, par value $0.001, 50,000,000 shares authorized, 16,655,207 and 16,650,725 shares issued and outstanding |
|
|
17 |
|
|
|
17 |
|
|
Additional paid-in capital |
|
|
58,580 |
|
|
|
58,520 |
|
|
Accumulated other comprehensive loss |
|
|
(211 |
) |
|
|
(176 |
) |
|
Accumulated deficit |
|
|
(17,667 |
) |
|
|
(13,883 |
) |
|
Total shareholders' equity |
|
|
40,719 |
|
|
|
44,478 |
|
|
Total liabilities and shareholders' equity |
|
$ |
52,571 |
|
|
$ |
55,110 |
|
See accompanying notes
CLEARONE, INC.
COMPREHENSIVE LOSS
(Dollars in thousands, except per share amounts)
|
|
|
Three months ended June 30, |
|
Six months ended June 30, | ||||||||||||
|
|
|
2020 |
|
|
2019 |
|
2020 | 2019 | ||||||||
|
Revenue |
|
$ |
6,357 |
|
|
$ |
6,420 |
|
$ | 12,091 | $ | 12,725 | ||||
|
Cost of goods sold |
|
|
3,739 |
|
|
|
3,481 |
|
6,635 | 7,082 | ||||||
|
Gross profit |
|
|
2,618 |
|
|
|
2,939 |
|
5,456 | 5,643 | ||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Operating expenses: |
|
|
|
|
|
|
|
|
||||||||
|
Sales and marketing |
|
|
1,457 |
|
|
|
2,261 |
|
3,196 | 4,214 | ||||||
|
Research and product development |
|
|
1,474 |
|
|
|
1,307 |
|
2,818 | 2,894 | ||||||
|
General and administrative |
|
|
1,526 |
|
|
|
1,475 |
|
3,032 | 3,030 | ||||||
|
Total operating expenses |
|
|
4,457 |
|
|
|
5,043 |
|
9,046 | 10,138 | ||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Operating loss |
|
|
(1,839 |
) |
|
|
(2,104 |
) |
(3,590 | ) | (4,495 | ) | ||||
|
|
|
|
|
|
|
|
|
|
||||||||
| Interest expense | (109 | ) | — | (217 | ) | — | ||||||||||
|
Other income, net |
|
|
16 |
|
|
|
51 |
|
51 | 93 | ||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Loss before income taxes |
|
|
(1,932 |
) |
|
|
(2,053 |
) | (3,756 | ) | (4,402 | ) | ||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Provision for income taxes |
|
|
5 |
|
|
|
45 |
|
28 | 45 | ||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net loss |
|
$ |
(1,937 |
) |
|
$ |
(2,098 |
) | $ | (3,784 | ) | $ | (4,447 | ) | ||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Basic weighted average shares outstanding |
|
|
16,650,774 |
|
|
|
16,630,770 |
|
16,650,750 | 16,630,684 | ||||||
|
Diluted weighted average shares outstanding |
|
|
16,650,774 |
|
|
|
16,630,770 |
|
16,650,750 | 16,630,684 | ||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Basic loss per share |
|
$ |
(0.12 |
) |
|
$ |
(0.13 |
) | $ | (0.23 | ) | $ | (0.27 | ) | ||
|
Diluted loss per share |
|
$ |
(0.12 |
) |
|
$ |
(0.13 |
) |
$ | (0.23 | ) | $ | (0.27 | ) | ||
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Comprehensive loss: |
|
|
|
|
|
|
|
|
||||||||
|
Net loss |
|
$ |
(1,937 |
) |
|
$ |
(2,098 |
) | $ | (3,784 | ) | $ | (4,447 | ) | ||
|
Unrealized gain on available-for-sale securities, net of tax |
|
|
30 |
|
|
84 |
7 | 154 | ||||||||
|
Change in foreign currency translation adjustment |
|
|
(8 |
) |
|
|
9 |
(42 | ) | (17 | ) | |||||
|
Comprehensive loss |
|
$ |
(1,915 |
) |
|
$ |
(2,005 |
) |
$ | (3,819 | ) | $ | (4,310 | ) | ||
See accompanying notes
CLEARONE, INC.
(Dollars in thousands, except per share amounts)
|
|
|
Six months ended June 30, |
|
|||||
|
|
|
2020 |
|
|
2019 |
|
||
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(3,784 |
) |
|
$ |
(4,447 |
) |
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |
|
|
|
|
|
|
|
|
|
Depreciation and amortization expense |
|
|
1,082 |
|
|
|
964 |
|
|
Amortization of right-of-use assets |
|
|
273 |
|
|
|
282 |
|
|
Stock-based compensation expense |
|
|
54 |
|
|
|
129 |
|
|
Provision for doubtful accounts, net |
|
|
31 |
|
|
|
40 |
|
|
Change of inventory to net realizable value |
|
|
660 |
|
|
|
368 |
|
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
|
Receivables |
|
|
(358 |
) |
|
|
251 |
|
|
Inventories |
|
|
2,331 |
|
|
|
1,840 |
|
|
Prepaid expenses and other assets |
|
|
238 |
|
|
584 |
||
|
Accounts payable |
|
|
302 |
|
|
(1,750 |
) |
|
|
Accrued liabilities |
|
|
(443 |
) |
|
|
255 |
|
|
Income taxes payable |
|
|
6 |
|
|
|
411 |
|
|
Deferred product revenue |
|
|
26 |
|
|
(44 |
) |
|
|
Operating lease liabilities |
|
|
(276 |
) |
|
|
(281 |
) |
| Other long-term liabilities | (29 | ) | — | |||||
|
Net cash provided by (used in) operating activities |
|
|
113 |
|
|
(1,398 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
Purchase of property and equipment |
|
|
(218 |
) |
|
|
(72 |
) |
|
Purchase of intangibles |
|
|
(114 |
) |
|
|
(24 |
) |
|
Capitalized patent defense costs |
|
|
(3,792 |
) |
|
|
(2,298 |
) |
|
Proceeds from maturities and sales of marketable securities |
|
|
2,482 |
|
|
|
2,011 |
|
|
Purchases of marketable securities |
|
|
(1,903 |
) |
|
|
(7,088 |
) |
|
Net cash used in investing activities |
|
|
(3,545 |
) |
|
|
(7,471 |
) |
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
| Net proceeds from Paycheck Protection Program loan | 1,499 | — | ||||||
|
Net proceeds from equity-based compensation programs |
|
|
6 |
|
|
|
16 |
|
|
Net cash provided by financing activities |
|
|
1,505 |
|
|
|
16 |
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents |
|
|
(31 |
) |
|
|
(6 |
) |
|
|
|
|
|
|
|
|
|
|
|
Net decrease in cash and cash equivalents |
|
|
(1,958 |
) |
|
|
(8,859 |
) |
|
Cash and cash equivalents at the beginning of the period |
|
|
4,064 |
|
|
|
11,211 |
|
|
Cash and cash equivalents at the end of the period |
|
$ |
2,106 |
|
|
$ |
2,352 |
|
See accompanying notes
CLEARONE, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in thousands, except per share amounts)
The following is a summary of supplemental cash flow activities:
|
|
|
Six Months Ended June 30, |
|
|||||
|
|
|
2020 |
|
|
2019 |
|
||
|
Cash paid for income taxes |
|
$ |
12 |
|
|
$ |
11 |
|
| Interest paid | 134 | — | ||||||
See accompanying notes
CLEARONE, INC.
(Unaudited - Dollars in thousands, except per share amounts)
1. Business Description, Basis of Presentation and Significant Accounting Policies
Business Description:
ClearOne, Inc., together with its subsidiaries (collectively, “ClearOne” or the “Company”), is a global market leader enabling conferencing, collaboration, and AV streaming solutions for voice and visual communications. The performance and simplicity of our advanced, comprehensive solutions offer unprecedented levels of functionality, reliability and scalability.
Basis of Presentation:
The fiscal year for ClearOne is the twelve months ending on December 31. The consolidated financial statements include the accounts of ClearOne and its subsidiaries. All significant inter-company accounts and transactions have been eliminated.
These accompanying interim unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and are not audited. Certain information and footnote disclosures that are usually included in financial statements prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) have been either condensed or omitted in accordance with SEC rules and regulations. The accompanying condensed consolidated financial statements contain all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of our financial position as of June 30, 2020 and December 31, 2019, the results of operations for the three and six months ended June 30, 2020 and 2019, and the cash flows for the six months ended June 30, 2020 and 2019. The results of operations for the three and six months ended June 30, 2020 and 2019 are not necessarily indicative of the results for a full-year period. These interim unaudited condensed consolidated financial statements should be read in conjunction with the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC.
Significant Accounting Policies:
The significant accounting policies were described in Note 1 to the audited consolidated financial statements included in the Company’s annual report on Form 10-K for the year ended December 31, 2019. There have been no changes to these policies during the six months ended June 30, 2020 that are of significance or potential significance to the Company.
Recent accounting pronouncements: The Company has determined that recently issued accounting standards will not have a material impact on its consolidated financial position, results of operations or cash flows.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited - Dollars in thousands, except per share amounts)
Liquidity:
As of June 30, 2020, our cash and cash equivalents were approximately $2,106 compared to $4,064 as of December 31, 2019. Our working capital was $13,765 as of June 30, 2020. Net cash provided by operating activities was $113 for the six months ended June 30, 2020, an increase of cash provided of $1,511 from $(1,398) of cash used in operating activities in the six months ended June 30, 2020.
We are currently pursuing all available legal remedies to defend our strategic patents from infringement. We have already spent approximately $17,383 from 2016 through June 30, 2020 towards this litigation and may be required to spend more to continue our legal defense. We believe the decision by the U.S. District Court in August 2019 granting our request for a preliminary injunction to prevent our competitor from manufacturing, marketing, and selling its competing ceiling microphone array in an infringing configuration is an incredibly valuable ruling for ClearOne and its business. We believe that the decision validates the strength and importance of ClearOne’s intellectual property rights, recognizes ClearOne’s innovations in this space, and stops our competitor from further infringing our Graham patent (U.S. Patent No. 9,813,806) pending a full trial. Although there can be no assurance of any outcome of a full trial, we believe this ruling will help pave the way for ClearOne’s recovery from the immense harm inflicted by our competitor's infringement of our valuable patents.
We have been actively engaged in preserving cash by suspending our dividend program and allowing our share repurchase program to expire in 2018 and implementing company-wide cost reduction measures. We have also raised additional capital in 2018 by issuing common stock, in 2019 by issuing senior convertible notes and in 2020 by borrowing through Paycheck Protection Program. In addition, we expect to generate additional cash as our inventory levels are brought down to historical levels.
We also believe that the measures taken by us will yield higher revenues in the future. We believe all of these and effective management of working capital will provide the liquidity needed to meet our operating needs through at least August 14, 2021. We also believe that our strong portfolio of intellectual property and our solid brand equity in the market will enable us to raise additional capital if and when needed to meet our short and long-term financing needs; however, there can be no assurance that, if needed, we will be successful in obtaining the necessary funds through equity or debt financing. If we need additional capital and are unable to secure financing, we may be required to further reduce expenses, delay product development and enhancement, or revise our strategy regarding ongoing litigation.
2. Revenue Information
The following table disaggregates the Company’s revenue into primary product groups:
|
|
|
Three months ended June 30, |
|
Six months ended June 30, | ||||||||||||
|
|
|
2020 |
|
|
2019 |
|
2020 | 2019 | ||||||||
|
Audio conferencing |
|
$ |
2,648 |
|
|
$ |
2,889 |
|
$ | 5,435 | $ | 5,600 | ||||
|
Microphones |
|
|
1,891 |
|
|
|
2,230 |
|
4,034 | 4,336 | ||||||
|
Video products |
|
|
1,818 |
|
|
|
1,301 |
|
2,622 | 2,789 | ||||||
|
|
|
$ |
6,357 |
|
|
$ |
6,420 |
|
$ | 12,091 | $ | 12,725 | ||||
The following table disaggregates the Company’s revenue into major regions:
|
|
|
Three months ended June 30, |
|
Six months ended June 30, |
||||||||||||
|
|
|
2020 |
|
|
2019 |
|
2020 | 2019 | ||||||||
|
North and South America |
|
$ |
4,003 |
|
|
$ |
3,493 |
|
$ | 7,355 | $ | 7,253 | ||||
|
Asia (including Middle East) and Australia |
|
|
1,580 |
|
|
|
1,969 |
|
2,996 | 3,833 | ||||||
|
Europe and Africa |
|
|
774 |
|
|
|
958 |
|
1,740 | 1,639 | ||||||
|
|
|
$ |
6,357 |
|
|
$ |
6,420 |
|
$ | 12,091 | $ | 12,725 | ||||
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited - Dollars in thousands, except per share amounts)
3. Earnings (Loss) Per Share
Earnings (loss) per common share is computed based on the weighted-average number of common shares outstanding and, when appropriate, dilutive potential common stock outstanding during the period. Stock options are considered to be potential common stock. The computation of diluted earnings (loss) per share does not assume exercise or conversion of securities that would have an anti-dilutive effect.
Basic earnings (loss) per common share is the amount of net earnings (loss) for the period available to each weighted-average share of common stock outstanding during the reporting period. Diluted earnings (loss) per common share is the amount of earnings (loss) for the period available to each weighted-average share of common stock outstanding during the reporting period and to each share of potential common stock outstanding during the period, unless inclusion of potential common stock would have an anti-dilutive effect.
The following table sets forth the computation of basic and diluted earnings (loss) per common share:
|
|
|
Three months ended June 30, |
|
Six months ended June 30, |
||||||||||||
|
|
|
2020 |
|
|
2019 |
|
2020 | 2019 | ||||||||
|
Numerator: |
|
|
|
|
|
|
|
|
||||||||
|
Net loss |
|
$ |
(1,937 |
) |
|
$ |
(2,098 |
) |
$ | (3,784 | ) | $ | (4,447 | ) | ||
|
Denominator: |
|
|
|
|
|
|
|
|
||||||||
|
Basic weighted average shares outstanding |
|
|
16,650,774 |
|
|
|
16,630,770 |
|
16,650,750 | 16,630,684 | ||||||
|
Dilutive common stock equivalents using treasury stock method |
|
|
— |
|
|
|
— |
|
— | — | ||||||
|
Diluted weighted average shares outstanding |
|
|
16,650,774 |
|
|
|
16,630,770 |
|
16,650,750 | 16,630,684 | ||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Basic loss per common share |
|
$ |
(0.12 |
) |
|
$ |
(0.13 |
) |
$ | (0.23 | ) | $ | (0.27 | ) | ||
|
Diluted loss per common share |
|
$ |
(0.12 |
) |
|
$ |
(0.13 |
) |
$ | (0.23 | ) | $ | (0.27 | ) | ||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Weighted average options outstanding |
|
|
542,196 |
|
|
|
569,997 |
|
542,507 | 578,543 | ||||||
|
Anti-dilutive options not included in the computations |
|
|
542,196 |
|
|
|
569,997 |
|
542,507 | 578,543 | ||||||
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited - Dollars in thousands, except per share amounts)
4. Marketable Securities
The Company has classified its marketable securities as available-for-sale securities. These securities are carried at estimated fair value with unrealized holding gains and losses included in accumulated other comprehensive income (loss) in stockholders’ equity until realized. Gains and losses on marketable security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned.
The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value for available-for-sale securities by major security type and class of securities at June 30, 2020 and December 31, 2019 were as follows:
|
|
|
Amortized cost |
|
|
Gross unrealized holding gains |
|
|
Gross unrealized holding losses |
|
|
Estimated fair value |
|
||||
|
June 30, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Available-for-sale securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds and notes |
|
$ |
1,916 |
|
|
$ |
37 |
|
|
$ |
(8 |
) |
|
$ |
1,945 |
|
|
Municipal bonds |
|
|
2,017 |
|
|
|
9 |
|
|
|
— |
|
|
|
2,026 |
|
|
Total available-for-sale securities |
|
$ |
3,933 |
|
|
$ |
46 |
|
|
$ |
(8 |
) |
|
$ |
3,971 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Available-for-sale securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds and notes |
|
$ |
1,814 |
|
|
$ |
21 |
|
|
$ |
(3 |
) |
|
$ |
1,832 |
|
|
Municipal bonds |
|
|
2,707 |
|
|
|
5 |
|
|
|
(1 |
) |
|
|
2,711 |
|
|
Total available-for-sale securities |
|
$ |
4,521 |
|
|
$ |
26 |
|
|
$ |
(4 |
) |
|
$ |
4,543 |
|
Maturities of marketable securities classified as available-for-sale securities were as follows at June 30, 2020:
|
|
|
Amortized cost |
|
|
Estimated fair value |
|
||
|
Due within one year |
|
$ |
2,827 |
|
|
$ |
2,841 |
|
|
Due after one year through five years |
|
|
1,106 |
|
|
|
1,130 |
|
|
Due after five years |
|
|
— |
|
|
|
— |
|
|
Total available-for-sale securities |
|
$ |
3,933 |
|
|
$ |
3,971 |
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited - Dollars in thousands, except per share amounts)
Debt securities in an unrealized loss position as of June 30, 2020 were not deemed impaired at acquisition and subsequent declines in fair value are not deemed attributed to declines in credit quality. Management believes that it is more likely than not that the securities will receive a full recovery of par value, although there can be no assurance that such recovery will occur. The available-for-sale marketable securities with continuous gross unrealized loss position for less than 12 months and 12 months or greater and their related fair values were as follows:
|
|
|
Less than 12 months |
|
|
More than 12 months |
|
|
Total |
|
|||||||||||||||
|
|
|
Estimated fair value |
|
|
Gross unrealized holding losses |
|
|
Estimated fair value |
|
|
Gross unrealized holding losses |
|
|
Estimated fair value |
|
|
Gross unrealized holding losses |
|
||||||
|
As of June 30, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds and notes |
|
$ |
189 |
|
|
$ |
8 |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
189 |
|
|
$ |
8 |
||
|
Municipal bonds |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Total |
|
$ |
189 |
|
|
$ |
8 |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
189 |
|
|
$ |
8 |
||
5. Intangible Assets
Intangible assets as of June 30, 2020 and December 31, 2019 consisted of the following:
|
|
|
Estimated useful lives (years) |
|
|
June 30, 2020 |
|
|
December 31, 2019 |
|
||||
|
Tradename |
|
5 |
to |
7 |
|
|
$ |
555 |
|
|
$ |
555 |
|
|
Patents and technological know-how |
|
|
10 |
|
|
|
|
22,400 |
|
|
|
18,494 |
|
|
Proprietary software |
|
3 |
to |
15 |
|
|
|
2,981 |
|
|
|
2,981 |
|
|
Other |
|
3 |
to |
5 |
|
|
|
323 |
|
|
|
323 |
|
|
Total intangible assets |
|
|
|
|
|
|
|
26,259 |
|
|
|
22,353 |
|
|
Accumulated amortization |
|
|
|
|
|
|
|
(9,118 |
) |
|
|
(8,344 |
) |
|
Total intangible assets, net |
|
|
|
|
|
|
$ |
17,141 |
|
|
$ |
14,009 |
|
The amortization of intangible assets for the three months ended June 30, 2020 and 2019 was as follows:
|
|
|
Three months ended June 30, |
|
Six months ended June 30, | ||||||||||||
|
|
|
2020 |
|
|
2019 |
|
2020 | 2019 | ||||||||
|
Amortization of intangible assets |
|
$ |
406 |
|
|
$ |
336 |
|
$ | 774 | $ | 700 | ||||
The estimated future amortization expense of intangible assets is as follows:
|
Years ending December 31, |
|
Amount |
|
|
|
2020 (Remainder) |
|
$ |
854 |
|
|
2021 |
|
|
1,708 |
|
|
2022 |
|
|
1,708 |
|
|
2023 |
|
|
1,701 |
|
|
2024 |
|
|
1,437 |
|
|
Thereafter |
|
|
9,733 |
|
|
Total |
|
|
17,141 |
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited - Dollars in thousands, except per share amounts)
6. Inventories
Inventories, net of reserves, as of June 30, 2020 and December 31, 2019 consisted of the following:
|
|
|
June 30, 2020 |
|
|
December 31, 2019 |
|
||
|
Current: |
|
|
|
|
|
|
|
|
|
Raw materials |
|
$ |
894 |
|
|
$ |
847 |
|
|
Finished goods |
|
|
7,330 |
|
|
|
10,594 |
|
|
|
|
$ |
8,224 |
|
|
$ |
11,441 |
|
|
|
|
|
|
|
|
|
|
|
|
Long-term: |
|
|
|
|
|
|
|
|
|
Raw materials |
|
$ |
2,999 |
|
|
$ |
1,915 |
|
|
Finished goods |
|
|
3,511 |
|
|
|
4,369 |
|
|
|
|
$ |
6,510 |
|
|
$ |
6,284 |
|
Long-term inventory represents inventory held in excess of our current (next 12 months) requirements based on our recent sales and forecasted level of sales. We expect to sell the above inventory, net of reserves, at or above the stated cost and believe that no loss will be incurred on its sale, although there can be no assurance of the timing or amount of any sales.
Net loss incurred on valuation of inventory at lower of cost or market value and write-off of obsolete inventory for the three months ended June 30, 2020 and 2019 was as follows:
|
|
|
Three months ended June 30, |
|
Six months ended June 30, | ||||||||||||
|
|
|
2020 |
|
|
2019 |
|
2020 | 2019 | ||||||||
|
Net loss incurred on valuation of inventory at lower of cost or market value and write-off of obsolete inventory |
|
$ |
459 |
|
|
$ |
183 |
|
$ | 660 | $ | 368 | ||||
7. Leases
Rent expense is recognized on a straight-line basis over the period of the lease taking into account future rent escalation and holiday periods.
Rent expense for the three months ended June 30, 2020 and 2019 was as follows:
|
|
|
Three months ended June 30, |
|
Six months ended June 30, | ||||||||||||
|
|
|
2020 |
|
|
2019 |
|
2020 | 2019 | ||||||||
|
Rent expense |
|
$ |
172 |
|
|
$ |
192 |
|
$ | 359 | $ | 363 | ||||
We occupy a 1,350 square-foot facility in Gainesville, Florida under the terms of an operating lease expiring in February 2023. The Gainesville facility is used primarily to support our research and development activities.
We occupy a 21,443 square-foot facility in Salt Lake City, Utah under the terms of an operating lease expiring in March 2024, with an option to extend for additional five years. The facility supports our principal administrative, sales, marketing, customer support, and research and product development activities.
We occupy a 950 square-foot facility in Austin, Texas - under the terms of an operating lease expiring in October 2022. This facility supports our sales, marketing, customer support, and research and development activities.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited - Dollars in thousands, except per share amounts)
We occupy a 3,068 square-foot facility in Zaragoza, Spain under the terms of an operating lease expiring in March 2022. This office supports our research and development and customer support activities.
We occupy a 6,175 square-foot facility in Chennai, India under the terms of an operating lease expiring in August 2021. This facility supports our administrative, marketing, customer support, and research and product development activities.
We occupy a 40,000 square-foot warehouse in Salt Lake City, Utah under the terms of an operating lease expiring in April 2025, which serves as our primary inventory fulfillment and repair center.
Supplemental cash flow information related to leases was as follows:
|
|
|
Six months ended June 30, |
|
|||||
|
|
|
2020 |
|
|
2019 |
|
||
|
Cash paid for amounts included in the measurement of lease liabilities |
|
|
|
|
|
|
||
| Operating cash flows from operating leases | $ | (356 | ) |
$ | (353 | ) |
||
| Right-of-use assets obtained in exchange for lease obligations: | ||||||||
| Operating leases | $ | 97 | $ | — | ||||
Supplemental balance sheet information related to leases was as follows:
|
|
|
June 30, 2020 |
|
|
December 31, 2019 |
|
||
|
Operating lease right-of-use assets |
|
$ |
2,227 |
|
|
$ |
2,459 |
|
|
|
|
|||||||
| Current portion of operating lease liabilities, included in accrued liabilities | $ | 596 | $ | 577 | ||||
|
Operating lease liabilities, net of current portion |
|
|
1,767 |
|
|
|
2,021 |
|
|
Total operating lease liabilities |
|
$ |
2,363 |
|
|
$ |
2,598 |
|
|
|
|
|
|
|
|
|
|
|
| Weighted average remaining lease term for operating leases (in years) | 4.0 | 4.4 | ||||||
| Weighted average discount rate for operating leases | 6.1 | % | 6.1 | % | ||||
The following represents maturities of operating lease liabilities as of June 30, 2020:
|
Years ending December 31, |
|
|
|
|
|
2020 (Remainder) |
|
$ |
362 |
|
|
2021 |
|
|
689 |
|
|
2022 |
|
|
634 |
|
|
2023 |
|
|
610 |
|
|
2024 |
|
|
306 |
|
|
Thereafter |
|
|
69 |
|
|
Total lease payments |
|
|
2,670 |
|
|
Less: Imputed interest |
|
|
(307 |
) |
|
Total |
|
$ |
2,363 |
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited - Dollars in thousands, except per share amounts)
8. Shareholders' Equity
|
|
|
Three months ended June 30, |
|
Six months ended June 30, | ||||||||||||
|
|
|
2020 |
|
|
2019 |
|
2020 | 2019 | ||||||||
|
Common stock and additional paid-in capital |
|
|
|
|
|
|
|
|
||||||||
|
Balance, beginning of period |
|
$ |
58,577 |
|
|
$ |
57,940 |
|
$ | 58,537 | $ | 57,857 | ||||
|
Share-based compensation expense |
|
|
17 |
|
|
|
55 |
|
54 | 129 | ||||||
|
Proceeds from employee stock purchase plan |
|
|
3 |
|
|
|
7 |
|
6 | 16 | ||||||
|
Balance, end of period |
|
$ |
58,597 |
|
|
$ |
58,002 |
|
$ | 58,597 | $ | 58,002 | ||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Accumulated other comprehensive loss |
|
|
|
|
|
|
|
|
||||||||
|
Balance, beginning of period |
|
$ |
(233 |
) |
|
$ |
(137 |
) |
$ | (176 | ) | $ | (181 | ) | ||
|
Unrealized gain on available-for-sale securities, net of tax |
|
|
30 |
|
|
84 |
7 | 154 | ||||||||
|
Foreign currency translation adjustment |
|
|
(8 |
) |
|
|
9 |
|
(42 | ) | (17 | ) | ||||
|
Balance, end of period |
|
$ |
(211 |
) |
|
$ |
(44 |
) |
$ | (211 | ) | $ | (44 | ) | ||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Retained earnings (accumulated deficit) |
|
|
|
|
|
|
|
|
||||||||
|
Balance, beginning of period |
|
$ |
(15,730 |
) |
|
$ |
(7,824 |
) | $ | (13,883 | ) | $ | (5,475 | ) | ||
|
Net loss |
|
|
(1,937 |
) |
|
|
(2,098 |
) |
(3,784 | ) | (4,447 | ) | ||||
|
Balance, end of period |
|
$ |
(17,667 |
) |
|
$ |
(9,922 |
) |
$ | (17,667 | ) | $ | (9,922 | ) | ||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Total shareholders' equity |
|
$ |
40,719 |
|
|
$ |
48,036 |
|
$ | 40,719 | $ | 48,036 | ||||
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited - Dollars in thousands, except per share amounts)
9. Long-Term Debt
Senior Convertible Notes and Warrants
On December 17, 2019, the Company completed the issuance and sale of $3,000 aggregate principal amount of secured convertible notes of the Company (the “Notes”) and warrants (the “Warrants”) to purchase 340,909 shares of common stock, par value $0.001 per share of the Company (the “Common Stock”), in a private placement transaction. The Notes and Warrants were issued and sold to Edward D. Bagley, an affiliate of the Company, on the terms and conditions of a Note Purchase Agreement dated December 8, 2019 between the Company, certain subsidiary guarantors of the Company, and Mr. Bagley. Mr. Bagley is an affiliate of the Company and was the beneficial owner of approximately 46.6% of the Company’s issued and outstanding shares of Common Stock at the time that the Notes and Warrants were issued to him.
The Notes will mature on December 17, 2023 (the “Maturity Date”) and will accrue interest at a variable rate adjusted on a quarterly basis and equal to two and one-half percent (2.5%) over the greater of (x) five and one-quarter percent (5.25%) and (y) the Prime Rate as published in the Wall Street Journal (New York edition) as of the beginning of such calendar quarter. The Notes may be converted into shares of the Company’s Common Stock at any time at the election of Mr. Bagley at an initial conversion price of $2.11 per share (the “Conversion Price”), or 120% of the closing price of the Common Stock on December 6, 2019 as reported on the Nasdaq Capital Market. Also, the Company can cause a mandatory conversion of the Notes if the volume weighted average closing price of the Common Stock over 90 consecutive trading days exceeds 200% of the Conversion Price. In addition, the Notes may be redeemed by the Company for cash at any time after December 17, 2020 upon payment of the outstanding principal balance of the Notes and any unpaid and accrued interest. The Company also is required to redeem the Notes upon the occurrence of a change in control of the Company.
The Warrants have an initial exercise price equal to $1.76, the closing price of the Common Stock on December 6, 2019 as reported on the Nasdaq Capital Market, and are exercisable until December 17, 2026. The Warrants must be exercised for cash, unless at the time of exercise there is not a then effective registration statement for the resale of the shares of Common Stock issuable upon exercise of the Warrants, in which case the Warrants may be exercised via a cashless exercise feature that provides for net settlement of the shares of Common Stock issuable upon exercise.
Concurrent with the issuance of the Notes and Warrants pursuant to the Note Purchase Agreement, the Company, the Guarantors and Mr. Bagley entered into a Guaranty and Collateral Agreement (the “Collateral Agreement”) pursuant to which the Company and the Guarantors granted Mr. Bagley a first priority lien interest in all of the Company’s assets as security for the Company’s performance of its obligations under the Notes and Warrants.
The net proceeds after original issue discount and issuance costs of $346 were approximately $2,654. The Company expects to use the proceeds from the sale of the Notes and Warrants for general corporate purposes and working capital.
In accounting for the issuance of the Notes, the Company separated Notes and Warrants into liability and equity components. The carrying amount of Warrants, being an equity component, was first calculated using Black-Scholes method with the following assumptions:
|
Risk-free interest rate |
1.82% |
|
Expected life of Warrants (years) |
7 |
|
Expected price volatility |
49.94% |
|
Expected dividend yield |
0% |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in thousands, except share and per share amounts)
The carrying amount of the Notes was then determined by deducting the fair value of the Warrants from the principal amount of the Notes. The carrying amount of the Notes was further separated into equity and liability components after separating the value of the conversion feature into an equity component and leaving the remaining value as liability. The equity component is not remeasured while the Notes and Warrants continue to meet the conditions for equity classification for equity components.
The original issue discount and issuance costs are netted against the liability. The following table represents the carrying value of Notes and Warrants:
|
|
|
June 30, 2020 |
|
|
December 31, 2019 |
|
||
|
Liability component: |
|
|
|
|
|
|
|
|
|
Principal |
|
$ |
3,000 |
|
|
$ |
3,000 |
|
|
Less: debt discount and issuance costs, net of amortization |
|
|
(680 |
) |
|
|
(778 |
) |
|
Net carrying amount |
|
$ |
2,320 |
|
|
$ |
2,222 |
|
|
Equity component(1): |
|
|
|
|
|
|
|
|
|
Warrants |
|
$ |
318 |
|
|
$ |
318 |
|
|
Conversion feature |
|
122 |
|
|
122 |
|
||
|
Net carrying amount |
|
$ |
440 |
|
|
$ |
440 |
|
(1) Recorded on the condensed consolidated balance sheets as additional paid-in capital.
Debt discount and issuance costs are amortized over the life of the note to interest expense using the effective interest method. During the three and six months ended June 30, 2020, amortization of debt discount and issuance costs was $49 and $98, respectively. The following table represents schedule of maturities of principal amount contained in the Notes as of June 30, 2020:
|
Year ending December 31, |
|
Principal Amount Maturing |
|
|
|
2020 |
|
$ |
— |
|
|
2021 |
|
|
360 |
|
|
2022 |
|
|
720 |
|
|
2023 |
|
|
1,920 |
|
| Total principal amount |
|
$ |
3,000 |
|
Paycheck Protection Program Loan
On April 18, 2020, the Company, entered into a loan agreement with U.S. Bank National Association Bank, which provided for a loan in the principal amount of $1,499 (“PPP Loan”) pursuant to the Paycheck Protection Program under Division A, Title I of the CARES Act, which was enacted March 27, 2020. The PPP Loan has a two-year term and bears interest at a rate of 1.0% per annum. Monthly principal and interest payments are deferred for six months after the date of disbursement.
The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. The PPP Loan contains events of default and other provisions customary for a loan of this type. The Paycheck Protection Program provides that the Loans may be partially or wholly forgiven if the funds are used for certain qualifying expenses as described in the CARES Act. The Company intends to use the entire PPP Loan amount for qualifying expenses and to apply for forgiveness of the PPP Loan in accordance with the terms of the CARES Act.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in thousands, except share and per share amounts)
10. Fair Value Measurements
The fair value of the Company’s financial instruments reflects the amounts that the Company estimates it will receive in connection with the sale of an asset or pay in connection with the transfer of a liability in an orderly transaction between market participants at the measurement date (exit price). The fair value hierarchy prioritizes the use of inputs used in valuation techniques into the following three levels:
Level 1 - Quoted prices in active markets for identical assets and liabilities.
Level 2 - Observable inputs other than quoted prices in active markets for identical assets and liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. This category generally includes U.S. Government and agency securities; municipal securities; mutual funds and securities sold and not yet settled.
Level 3 - Unobservable inputs.
The substantial majority of the Company’s financial instruments are valued using observable inputs. The following table sets forth the fair value of the financial instruments re-measured by the Company as of June 30, 2020 and December 31, 2019:
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
||||
|
June 30, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds and notes |
|
$ |
— |
|
|
$ |
1,945 |
|
|
$ |
— |
|
|
$ |
1,945 |
|
|
Municipal bonds |
|
|
— |
|
|
|
2,026 |
|
|
|
— |
|
|
|
2,026 |
|
|
Total |
|
$ |
— |
|
|
$ |
3,971 |
|
|
$ |
— |
|
|
$ |
3,971 |
|
|
December 31, 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds and notes |
|
$ |
— |
|
|
$ |
1,832 |
|
|
$ |
— |
|
|
$ |
1,832 |
|
|
Municipal bonds |
|
|
— |
|
|
|
2,711 |
|
|
|
— |
|
|
|
2,711 |
|
|
Total |
|
$ |
— |
|
|
$ |
4,543 |
|
|
$ |
— |
|
|
$ |
4,543 |
|
11. Income Taxes
The current year loss did not result in income tax benefit due to recording a full valuation allowance against expected benefits. The valuation allowance was recorded as we concluded that it was more likely than not that our deferred tax assets were not realizable primarily due to the Company's recent pre-tax losses. Provision for income taxes for the six months ended June 30, 2020 represents income tax expense recorded for jurisdictions outside the United States.
12. Subsequent events
None.
This report on Form 10-Q includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements in this report, other than statements of historical fact, are forward-looking statements for purposes of these provisions, including any projections of earnings, revenues or other financial items, any statements of the plans and objectives of management for future operations, any statements concerning proposed new products or services, any statements regarding future economic conditions or performance, and any statements of assumptions underlying any of the foregoing. All forward-looking statements included in this report are made as of the date hereof and are based on information available to us as of such date. We assume no obligation to update any forward-looking statement. In some cases, forward-looking statements can be identified by the use of terminology such as “may,” “will,” “expects,” “plans,” “anticipates,” “intends,” “believes,” “estimates,” “potential,” or “continue,” or the negative thereof or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements contained herein are based upon reasonable assumptions at the time made, there can be no assurance that any such expectations or any forward-looking statement will prove to be correct. Our actual results will vary, and may vary materially, from those projected or assumed in the forward-looking statements. Future financial condition and results of operations, as well as any forward-looking statements, are subject to inherent risks and uncertainties, many of which we cannot predict with accuracy and some of which we might not anticipate, including, without limitation, product recalls and product liability claims; infringement of our technology or assertion that our technology infringes the rights of other parties; termination of supplier relationships, or failure of suppliers to perform; inability to successfully manage growth; delays in obtaining regulatory approvals or the failure to maintain such approvals; concentration of our revenue among a few customers, products or procedures; development of new products and technology that could render our products obsolete; market acceptance of new products; introduction of products in a timely fashion; price and product competition, availability of labor and materials, cost increases, and fluctuations in and obsolescence of inventory; volatility of the market price of our common stock; foreign currency fluctuations; changes in key personnel; work stoppage or transportation risks; integration of business acquisitions; and other factors referred to in our reports filed with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2019. All subsequent forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Additional factors that may have a direct bearing on our operating results are discussed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019.
BUSINESS OVERVIEW
ClearOne is a global Company that designs, develops and sells conferencing, collaboration, and AV networking solutions for voice and visual communications. The performance and simplicity of our advanced, comprehensive solutions offer a high level of functionality, reliability and scalability. We derive a major portion of our revenue from audio conferencing products and microphones by promoting our products in the professional audio-visual channel. We have extended our total addressable market from the installed audio conferencing market to adjacent complementary markets – microphones, video collaboration and AV networking. We have achieved this through strategic technological acquisitions as well as by internal product development.
During the first quarter of 2020, we announced two new additions to our COLLABORATE Versa family of products. COLLABORATE® Versa Room CT, provides all the equipment and accessories needed for exceptional room cloud-based conferencing. At the heart of the system, is the USB audio-enabled Beamforming Mic Array Ceiling Tile (BMA CTH). Thanks to its onboard processing, the BMA CTH performs acoustic echo cancellation, noise cancellation, and beam selection, so no external DSP mixer is required. The array’s adaptive steering (think of it as smart switching) provides impeccable room coverage. The Versa Room CT brings cost-effective professional conferencing audio to small and mid-sized meeting rooms.
COLLABORATE Versa Lite CT is a USB audio enabled BMA CTH room solution. This solution dramatically enhances the audio experience for any cloud-collaboration application such as COLLABORATE Space, Zoom™, Microsoft® Teams, and Webex™, without the need for a DSP mixer. The system can be easily and quickly configured using ClearOne’s CONSOLE® AI Lite software with Audio Intelligence™ and Auto Connect™. A laptop or a desktop PC can be connected to the BMA CTH directly through the USB port on the USB Expander to share room audio. The included 50-foot CAT6 cable connects the USB Expander to the BMA CTH.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
During February 2020, we announced a new Touch-Panel Controller, a highly intuitive 10-inch touch-screen device, designed for ClearOne’s CONVERGE® Pro 2 audio DSP mixers as well as COLLABORATE Live video conferencing room systems. Paired with CONVERGE Pro 2 DSP mixers, users can make and receive PSTN and/or VoIP conference calls, and multiparty calls with the easy-to-use on-screen dial pad. When paired with COLLABORATE Live, users can make and receive video calls as well as manage content sharing options.
COLLABORATE Space, our powerful cloud-based collaboration solution, added two new valuable features - webinar hosting and Web RTC. COLLABORATE Space Pro and Enterprise meeting plans can be upgraded to include the new Webinar feature allowing session hosts to conduct video and audio presentations for up to 1000 participants. The new Web RTC feature works with all popular browsers including Microsoft Edge, Google Chrome, Safari and Mozilla Firefox. The new Web RTC feature enables users to easily join full-featured COLLABORATE Space audio and video meetings using a browser with no downloads or plug-ins required. Users can accept meeting, webinar, and classroom invitations and join with a single click; easily sharing and viewing content within a browser window. COLLABORATE Space also added a feature where Microsoft Teams users can now enjoy a richer collaboration than that available within the Teams environment today. This richer collaboration experience includes better video quality, support for multiple cameras, support for multiple displays, and a persistent meeting space where chats, audio and video recordings, documents, meeting minutes, whiteboard sessions, and more can be shared in private or public channels for later access. Users can easily initiate a Space video meeting or join an existing Space video meeting within the MS Teams environment.
During April 2020, we introduced UNITE 20 Pro Webcam, which easily mounts on a PC or laptop to provide full 1080p30 image with an ultra wide-angle field-of-view up to 120°. A super-high signal-to-noise ratio and advanced 2D and 3D noise reduction provides superior desktop camera video quality.
During the first six months of 2020, we continued our efforts, primarily through litigation, to stop the infringement of our strategic patents. We also continued our programs to cut costs and to speed up product development that we believe will enable us to get back to a growth path.
Overall revenue declined by 1% in the second quarter of 2020 when compared to the second quarter of 2019, primarily due to a decline in audio conferencing products and microphones mostly offset by an increase in revenue from video products. Despite the negative impact of COVID-19 and the infringement of our patents by Shure on all professional installed products our new solutions incorporating Beamforming Microphone Array Ceiling Tile ("BMA-CT") resulted in overall Beamforming Microphone Array ("BMA") revenue being significantly higher than last year. However, revenue from BMA products as well as from our pro audio products are far below the levels prior to infringement of our patents. Our revenue performance reflects an impact of the on-going harm of infringement of ClearOne’s patents despite the preliminary injunction granted against Shure as we believe Shure continues to infringe our patents and violates the preliminary injunction. The patent infringement also has negatively impacted directly the revenue from ClearOne’s other products not related to the infringed patents. Our gross profit margin decreased to 41% during the second quarter of 2020 from 46% during the second quarter of 2019. Net loss decreased from $2.1 million in the second quarter of 2019 to $1.9 million in the second quarter of 2020. The decrease was mainly due to reduction in operating costs.
During the first six months ended June 30, 2020 our revenues decreased by 5% when compared to the six months ended June 30, 2019. The decline was seen in all product categories. Our gross profit margin increased to 45% during the first six months of 2020 from 44% during the same six months of 2019. Net loss decreased from $4.4 million in the first six months of 2019 to $3.8 million in the first six months of 2020. The decrease was mainly due to reduction in operating costs and increased gross margin.
We believe the decision by the U.S. District Court in August 2019 granting our request for a preliminary injunction to prevent Shure from manufacturing, marketing, and selling its competing ceiling microphone array in an infringing configuration is an incredibly valuable ruling for ClearOne and its business. The decision validates the strength and importance of ClearOne’s intellectual property rights, recognizes ClearOne’s innovations in this space, and stops Shure from further infringing the Graham patent pending a full trial. Although there can be no assurance of any outcome of a full trial, we believe this ruling will help pave the way for ClearOne’s recovery from the immense harm inflicted by Shure's infringement of our valuable patents. However, we are not getting the full benefits of the Court’s extraordinary remedy in the form of the preliminary injunction granted against Shure with respect to infringement of our ’806 Patent as we believe that Shure, still infringes ClearOne’s patent. We have sought a Court order holding Shure in contempt for marketing and selling their new design in violation of the preliminary injunction.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Industry conditions
We operate in a very dynamic and highly competitive industry which is dominated on the one hand by a few players with respect to certain products like traditional video conferencing appliances while on the other influenced heavily by a fragmented reseller market consisting of numerous regional and local players. The industry is also characterized by venture capitalist funded start-ups and private companies willing to fund cumulative cash losses in order to gain market share and achieve certain non-financial goals.
Economic conditions, challenges and risks
The audio-visual products market is characterized by intense competition and rapidly evolving technology. Our competitors vary within each product category. Our installed professional audio conferencing products, which is our flagship product category, continue to be ahead of the competition despite the reduction in revenues. Our strength in this space is largely due to our fully integrated suite of products consisting of DSP mixers, wide range of professional microphone products and video collaboration products. Despite our strong leadership position in the installed professional audio conferencing market, we face challenges to revenue growth due to the limited size of the market and pricing pressures from new competitors attracted to the commercial market due to higher margins.
Revenue from our video products are critical to our long-term growth due to significantly larger available market space for video products. We face intense competition in this market from well-established market leaders, emerging players rich with marketing funds and information technology giants offering free products and services. We expect our strategy of combining COLLABOATE Space, our cloud-based video conferencing product with COLLABORATE Live, our appliance-based media collaboration product, UNITE, our high-quality professional cameras, and our high-end audio conferencing technology will generate high growth in the near future. We believe we are also well positioned with our COLLABORATE Versa solutions incorporated with BMA-CT to capitalize on the acceleration of replacing large meeting rooms with huddle rooms.
We derive a major portion of our revenue (approximately 46% for the year ended December 31, 2019) from international operations and expect this trend to continue in the future. Most of our revenue from outside the U.S. is billed in U.S. dollars and is not exposed to any significant currency risk. However, we are exposed to foreign exchange risk if the U.S. dollar is strong against other currencies as it will make U.S. Dollar denominated prices of our products less competitive.
In December 2019, a novel strain of coronavirus (“COVID-19”) was first reported in Wuhan, China. The COVID-19 pandemic has continued to spread and has already caused severe global disruptions. The extent of COVID-19’s effect on our operational and financial performance will depend on future developments, including the duration, spread and intensity of the pandemic, all of which are uncertain and difficult to predict considering the rapidly evolving landscape. If the pandemic continues to evolve into a severe worldwide health crisis, the disease could have a material adverse effect on our business, results of operations, financial condition and cash flows and adversely impact the trading price of our common stock.
Deferred Revenue
Deferred revenue remained almost the same at $0.20 million at June 30, 2020 compared to $0.17 million at December 31, 2019.
A detailed discussion of our results of operations follows below.
Results of Operations for the three and six months ended June 30, 2020
The following table sets forth certain items from our unaudited condensed consolidated statements of operations for the three and six months ended June 30, 2020 (“2020-Q2”) ("2020-YTD") and 2019 ("2019-Q2") ("2019-YTD"), respectively, together with the percentage of total revenue which each such item represents:
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
Three months ended June 30, |
Six months ended June 30, |
|||||||||||||||||||||||
| (dollars in thousands) |
2020 |
2019 |
Percentage Change 2020 vs 2019 |
2020 |
2019 |
Percentage Change 2020 vs 2019 |
||||||||||||||||||
|
Revenue |
$ | 6,357 | $ | 6,420 | -1 | % | $ | 12,091 | $ | 12,725 | -5 | % | ||||||||||||
|
Cost of goods sold |
3,739 | 3,481 | 7 | % | 6,635 | 7,082 | -6 | % | ||||||||||||||||
|
Gross profit |
2,618 | 2,939 | -11 | % | 5,456 | 5,643 | -3 | % | ||||||||||||||||
|
Sales and marketing |
1,457 | 2,261 | -36 | % | 3,196 | 4,214 | -24 | % | ||||||||||||||||
|
Research and product development |
1,474 | 1,307 | 13 | % | 2,818 | 2,894 | -3 | % | ||||||||||||||||
|
General and administrative |
1,526 | 1,475 | 3 | % | 3,032 | 3,030 | 0 | % | ||||||||||||||||
|
Total operating expenses |
4,457 | 5,043 | -12 | % | 9,046 | 10,138 | -11 | % | ||||||||||||||||
|
Operating loss |
(1,839 | ) | (2,104 | ) | -13 | % | (3,590 | ) | (4,495 | ) | -20 | % | ||||||||||||
|
Other income (expense), net |
(93) | 51 | -282 | % | 51 | 93 | -45 | % | ||||||||||||||||
|
Loss before income taxes |
(1,932 | ) | (2,053 | ) | -6 | % | (3,756 | ) | (4,402 | ) | -15 | % | ||||||||||||
|
Provision for income taxes |
5 | 45 | -89 | % | 28 | 45 | -38 | % | ||||||||||||||||
|
Net loss |
$ | (1,937) | $ | (2,098 | ) | -8 | % | $ | (3,784) | $ | (4,447 | ) | -15 | % | ||||||||||
Revenue
Our revenue decreased to $6.36 million in 2020-Q2 compared to $6.42 million in 2019-Q2 primarily due to an 8% decline in audio conferencing products and 15% decline in microphones category offset mostly by 40% increase in revenue from video products. Microphones category as a whole declined despite significant increase in revenues from BMA products. During the second quarter of 2020, revenue from North America increased by 15% while revenues from Asia Pacific, including the Middle East declined by 20% and revenues from Europe and Africa declined by 19%. Overall USA, Canada and Japan registered impressive growths, while China, India and the Middle East saw significant declines.
During the six months ended June 30, 2020 our revenues declined from $12.7 million to $12.1 million compared to same period in 2019 due to decline in all product categories, namely audio conferencing by 3%, microphones category by 7% and video products by 6%. During the six months ended June 30, 2020 revenues in Americas increased by 1% compared to same period in 2019. The Asia Pacific, including the Middle East declined by 22% and the Europe and Africa increased by 6%.
We believe, although there can be no assurance, that we will return to a growth path if we are able to successfully implement our strategic initiatives focused on product innovation, cost reduction and defense of our intellectual property.
Costs of Goods Sold and Gross Profit
Cost of goods sold includes expenses associated with finished goods purchased from outsourced manufacturers, the repackaging of our products, our manufacturing and operations organization, property and equipment depreciation, warranty expense, freight expense, royalty payments, and the allocation of overhead expenses.
Our gross profit margin decreased to 41% during 2020-Q2 from 46% during 2019-Q2. Gross profit declined due to increase in the share of lower margin products in the revenue mix, increased freight and tariff costs and increased inventory obsolescence costs, partially offset by a decrease in overhead costs.
Our gross profit margin decreased to 45% during 2020-H1 from 44% during 2019-H1. The gross profit margin increased primarily due to increase of higher-margin professional audio conferencing products in the revenue mix and reduction in overhead costs, partially offset by increase in inventory obsolescence costs.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Our profitability in the near-term continues to depend significantly on our revenues from professional installed audio-conferencing products. We hold long-term inventory and if we are unable to sell our long-term inventory, our profitability might be affected by inventory write-offs and price mark-downs. Our long-term inventory includes approximately $1.5 million of wireless microphone-related finished goods and assemblies, $1.4 million of Converge Pro and Beamforming microphone array products, $0.5 million of network media streaming products and about $2.3 million of raw materials that will be used for manufacturing professional audio conferencing products. Any business changes that are adverse to these product lines could potentially impact our ability to sell our long-term inventory in addition to our current inventory.
Operating Expenses
Operating expenses include sales and marketing (“S&M”) expenses, research and product development (“R&D”) expenses and general and administrative (“G&A”) expenses. Total operating expenses were $4.5 million for 2020-Q2 compared to $5.0 million for 2019-Q2. Total operating expenses were $9.0 million for 2020-H1 compared to $10.1 million for 2019-H1. The following contains a more detailed discussion of expenses related to sales and marketing, research and product development, general and administrative, and other items.
Sales and Marketing - S&M expenses include selling, customer service, and marketing expenses such as employee-related costs, allocations of overhead expenses, trade shows, and other advertising and selling expenses.
S&M expenses for 2020-Q2 decreased to $1.5 million from $2.3 million for 2019-Q2. The decrease was mainly due to decreases in trade-show related expenses, demonstration inventory costs, employee travel related expenses, and independent rep commissions, partially offset by an increase in employee benefits expenses.
S&M expenses for 2020-H1 decreased to $3.2 million from $4.2 million for 2019-H1. The decrease was mainly due to decreases in trade-show related expenses, demonstration inventory costs, employee related costs and commissions paid to independent reps.
Research and Product Development - R&D expenses include research and development, product line management, engineering services, and test and application expenses, including employee-related costs, outside services, expensed materials, depreciation, and an allocation of overhead expenses.
R&D expenses were approximately $1.5 million for 2020-Q2, as compared to $1.3 million for 2019-Q2. The increase was primarily due to increases in employee-related costs.
R&D expenses remained fairly consistent with approximately $2.8 million for 2020-H1, as compared to $2.9 million for 2019-H1.
General and Administrative - G&A expenses include employee-related costs, professional service fees, allocations of overhead expenses, litigation costs, and corporate administrative costs, including costs related to financing and human resources.
G&A expenses remained consistent at $1.5 million in 2020-Q2 and 2019-Q2.
G&A expenses remained consistent at $3.0 million in 2020-H1 compared to $3.0 million in 2019-H1.
Other income (expense), net
Other income (expense), net, includes interest income and foreign currency changes. Other income remained fairly consistent between the second quarter of 2020 and 2019 and between 2020-H1 and 2019-H1.
Interest expense in the second quarter of 2020 was $109 thousand compared to no interest expense in the second quarter of 2019. Most of the interest expense was incurred due to issuance of senior convertibles notes with a face value of $3.0 million in December 2019.
Interest Expense in 2020-H1 was $217 thousand compared to no interest expense in 2019-H1. Most of the interest expense was incurred due to issuance of senior convertibles notes with a face value of $3.0 million in December 2019.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Provision for income taxes
During 2020-H1, we did not recognize any benefit from the losses incurred due to setting up of full valuation allowance. Provision for income taxes recognized for 2020-Q2 and 2020-H1 relates to foreign jurisdictions.
LIQUIDITY AND CAPITAL RESOURCES
As of June 30, 2020, our cash and cash equivalents were approximately $2.1 million compared to $4.1 million as of December 31, 2019. Our working capital was $13.8 million and $18.9 million as of June 30, 2020 and December 31, 2019, respectively.
Net cash provided by operating activities was approximately $0.1 million in 2020-H1, an increase of cash provided of approximately $1.5 million from $1.4 million of cash used in operating activities in 2019-H1. The increase in cash inflow was due to positive change in operating assets and liabilities of $0.5 million, increase in non-cash charges by $0.3 million and a decrease in net loss by $0.7 million.
Net cash used in investing activities was $3.5 million for 2020-Q2 compared to net cash used in investing activities of $7.5 million during the 2019-Q2, a decrease in cash used of $3.9 million. The decrease in cash used in investing activities was primarily due to a decrease in net cash outflows from marketable securities of approximately $5.7 million partially offset by an increase in capitalized patent defense costs by $1.7 million.
Capitalization of patent defense costs. We capitalize external legal costs incurred in the defense of our patents when we believe that a significant, discernible increase in value will result from the defense and a successful outcome of the legal action is probable. When we capitalize patent defense costs we amortize the costs over the remaining estimated useful life of the patent, which is 15 to 17 years. During 2020-Q2 we spent $2.1 million on legal costs related to the defense of our patents and capitalized the entire amount.
We are currently pursuing all available legal remedies to defend our strategic patents from infringement. We have already spent approximately $17.4 million from 2016 through June 30, 2020 towards this litigation and may be required to spend more to continue our legal defense. We believe the decision by the U.S. District Court in August 2019 granting our request for a preliminary injunction to prevent our competitor from manufacturing, marketing, and selling its competing ceiling microphone array in an infringing configuration is an incredibly valuable ruling for ClearOne and its business. We believe that the decision validates the strength and importance of ClearOne’s intellectual property rights, recognizes ClearOne’s innovations in this space, and stops our competitor from further infringing our Graham patent (U.S. Patent No.9,813,806) pending a full trial. Although there can be no assurance of any outcome of a full trial, we believe this ruling will help pave way for ClearOne’s recovery from the immense harm inflicted by our competitor's infringement of our valuable patents. However, we are not getting the full benefits of the Court’s extraordinary remedy in the form of the preliminary injunction granted against Shure with respect to infringement of our ’806 Patent as we believe that Shure, still infringes ClearOne’s patent. We have sought a Court order holding Shure in contempt for marketing and selling their new design in violation of the preliminary injunction.
We have been actively engaged in preserving cash by suspending our dividend program and allowing our share repurchase program to expire in 2018 and implementing company-wide cost reduction measures. During 2018, we raised additional proceeds of $9.9 million (net of issuance costs) from the Rights Offering. During December 2019 we raised approximately $2.7 million (net of issuance costs) from the issue of senior convertible notes. We also believe additional cash will be generated as we continue to consume our inventory and bring it down to historical levels.
We also believe that the measures taken by us will yield higher revenues in the future. We believe all of these and effective management of working capital will provide the liquidity needed to meet our operating needs through at least August 14, 2021. We also believe that our strong portfolio of intellectual property and our solid brand equity in the market will enable us to raise additional capital if and when needed to meet our short and long-term financing needs; however, there can be no assurance that, if needed, we will be successful in obtaining the necessary funds through equity or debt financing. If we need additional capital and are unable to secure financing, we may be required to further reduce expenses, delay product development and enhancement, or revise our strategy regarding ongoing litigation.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
At June 30, 2020, we had open purchase orders of approximately $1.9 million for purchase of inventory.
At June 30, 2020, we had inventory totaling $14.7 million, of which non-current inventory accounted for $6.5 million. This compares to total inventories of $17.7 million and non-current inventory of $6.3 million as of December 31, 2019.
Contractual Obligations and Commitments
The following table summarizes our contractual obligations as of June 30, 2020 (in millions):
|
|
|
Payment Due by Period |
|
|||||||||||||||||
|
|
|
Total |
|
|
Less Than 1 Year |
|
|
1-3 Years |
|
|
3-5 Years |
|
|
More than 5 years |
|
|||||
|
Senior convertible notes |
|
$ |
3.0 |
|
|
$ |
0.2 |
|
|
$ |
1.3 |
|
|
$ |
1.5 |
|
|
$ |
— |
|
| Payroll Protection Plan loan | 1.5 | — | 1.5 | — | — | |||||||||||||||
|
Operating lease obligations |
|
|
2.7 |
|
|
|
0.5 |
|
|
|
1.4 |
|
|
|
0.8 |
|
|
|
— |
|
|
Purchase obligations |
|
|
1.9 |
|
|
|
1.9 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Total |
|
$ |
9.1 |
|
|
$ |
2.6 |
|
|
$ |
4.2 |
|
|
$ |
2.3 |
|
|
$ |
— |
|
OFF-BALANCE SHEET ARRANGEMENTS
We have no off-balance-sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, changes in financial conditions, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources, results of operations or liquidity.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Our discussion and analysis of our results of operations and financial position are based upon our unaudited consolidated financial statements included under Item 1 of this Form 10-Q, which have been prepared in conformity with accounting principles generally accepted in the United States. We review the accounting policies used in reporting our financial results on a regular basis. We believe certain of our accounting policies are critical to understanding our financial position and results of operations. There have been no changes to the critical accounting policies as explained in our Annual Report on Form 10-K for the year ended December 31, 2019.
RECENT ACCOUNTING PRONOUNCEMENTS
For a discussion of recent accounting pronouncements, see Note 1: “Business Description, Basis of Presentation and Significant Accounting Policies” in the notes to our unaudited condensed consolidated financial statements included under Item 1 of this Form 10-Q.
Not applicable.
An evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of June 30, 2020 was performed under the supervision and with the participation of our management, including our Chief Executive Officer and our Principal Financial and Accounting Officer. Based upon this evaluation, our Chief Executive Officer and Senior Vice President of Finance concluded that, as of the end of the period covered by this Quarterly Report, our disclosure controls and procedures effective at a reasonable assurance level as of June 30, 2020.
There has been no change in the Company's internal control over financial reporting as of June 30, 2020, that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.
There have been no material developments to the legal proceedings discussed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019.
There have been no material changes to the risk factors included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019.
(a) None.
Not applicable.
Not applicable.
Not applicable.
|
Exhibit No. |
|
Title of Document |
|
|
|
|
|
31.1 |
|
Section 302 Certification of Chief Executive Officer (filed herewith) |
|
|
|
|
|
31.2 |
|
Section 302 Certification of Principal Financial Officer (filed herewith) |
|
|
|
|
|
32.1 |
|
Section 906 Certification of Chief Executive Officer (filed herewith) |
|
|
|
|
|
32.2 |
|
Section 906 Certification of Principal Financial Officer (filed herewith) |
|
|
|
|
|
101.INS |
|
XBRL Instance Document (filed herewith) |
|
|
|
|
|
101.SCH |
|
XBRL Taxonomy Extension Schema (filed herewith) |
|
|
|
|
|
101.CAL |
|
XBRL Taxonomy Extension Calculation Linkbase (filed herewith) |
|
|
|
|
|
101.DEF |
|
XBRL Taxonomy Extension Definitions Linkbase (filed herewith) |
|
|
|
|
|
101.LAB |
|
XBRL Taxonomy Extension Label Linkbase (filed herewith) |
|
|
|
|
|
101.PRE |
|
XBRL Taxonomy Extension Presentation Linkbase (filed herewith) |
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
ClearOne, Inc., (Registrant) |
|
|
|
|
|
|
|
By: |
/s/ Zeynep Hakimoglu |
|
August 13, 2020 |
|
Zeynep Hakimoglu President, Chief Executive Officer and Chairman of the Board (Principal Executive Officer) |
|
|
|
|
|
|
By: |
/s/ Narsi Narayanan |
|
August 13, 2020 |
|
Narsi Narayanan Senior Vice President of Finance (Principal Accounting and Principal Financial Officer) |
| 26 |